HHS Office of Inspector General finds continuing problems in federal provider-identification databases
Will inaccuracies in the National Plan and Provider Enumeration System (NPPES) create headaches for pharma?
On the verge of when the pharma industry needs to get serious about collecting and aggregating spending data on physicians, the Physician's Payment Sunshine Act, the HHS OIG came out with a report again castigating HHS for the inability of its contractors to maintain federal databases identifying names, affiliations and locations of providers. The OIG report (issued in late May; tip of the hat to SK&A Information for highlighting the study), Improvements Needed to Ensure Provider Enumeration and Medicare Enrollment, found that provider data were inaccurate in 48% of records, and incomplete in 9% of records; there were also inconsistencies affecting nearly all records when NPPES and the provider Enrollment, Chain and Ownership System (PECOS), another HHS database used for provider data.
In truth, the inaccuracies seldom included the National Provider Identifier (NPI), the key ID number for physicians and other providers, and the one that most pharma-industry databases are keyed to; more often, the inaccuracy involved address information. And these databases are more important to the Medicare payments that CMS makes, and for preventing fraud and abuse in that program, than for pharma’s agg-spend requirements. But the continuing difficulty highlights the complexity of keeping track, through regularly updated master-data lists, of the providers that the pharma industry interacts with.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.
